Home
Conditions
Triple Negative Breast Neoplasms

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

818 public trials 296 recruiting studies

Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Recruiting

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

NCT06451497

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +58 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

NEXT Oncology Austin, TX 78758, Texas, United States

NEXT Oncology San Antonio, Texas, United States

View Trial Details

Recruiting

Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK

NCT06358573

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +6 more
Locations: Tumor Zentrum Aarau Aarau, Switzerland

St. Claraspital Basel, Switzerland

EOC - IOSI Ospedale regionale Bellinzona e valli - San Giovanni Bellinzona, Switzerland

Kantonsspital Graubünden Chur, Switzerland

View Trial Details

Recruiting

Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer

NCT06365788

Conditions: Breast Diseases, Breast Neoplasms, Bulbo-Spinal Atrophy, X-Linked, +16 more
Locations: ZAS Augustinus Antwerp, Belgium

Antwerp University Hospital Antwerp, Belgium

University Hospital Brussels Brussels, Belgium

Ghent University Hospital Ghent, Belgium

View Trial Details

Recruiting

Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy

NCT06435351

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Recruiting

Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer

NCT06768931

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
Locations: Gansu Cancer Hospital Lanzhou, Gansu, China

Dongguan People's Hospital Dongguan, Guangdong, China

Sun yat sen university cancer center Guangzhou, Guangdong, China

Central Hospital of Guangdong Nongken Zhanjiang, Guangdong, China

View Trial Details

Recruiting

Breast Cancer PSMA PET

NCT06586047

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: University of Iowa Healthcare Iowa City, Iowa, United States

View Trial Details

Recruiting

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

NCT07189871

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +60 more
Locations: Dothan Hematology & Oncology Dothan, Alabama, United States

BAMF Health Grand Rapids, Michigan, United States

Nebraska Cancer Specialists Omaha, Nebraska, United States

XCancer Omaha, Nebraska, United States

View Trial Details

Recruiting

Precise Treatment for BLIS Subtype of TNBC in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer

NCT05806060

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Breast cancer institute of Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer

NCT06831955

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: UZ Antwerpen Antwerp, Belgium

Ziekenhuis aan de Stroom Antwerp, Belgium

Cliniques universitaires Saint-Luc (UCLouvain) Brussels, Belgium

UZ Brussel Brussels, Belgium

View Trial Details

Recruiting

Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)

NCT07486089

Conditions: Breast Cancer (Locally Advanced or Metastatic), Breast Diseases, Breast Neoplasms, +11 more
Locations: Peking University Shenzhen Hospital Shenzhen, Guangdong, China

View Trial Details

Triple Negative Breast Neoplasms

Triple Negative Breast Neoplasms trial results

Related conditions